MedPath

A clinical trial to study the effects of two methods of surfactant administration, through Laryngeal mask airway and endotracheal tube in preterm babies with Respiratory distress syndrome

Phase 2/3
Recruiting
Conditions
Respiratory distress syndrome
Registration Number
CTRI/2016/12/007540
Lead Sponsor
Dr Ramkumaar
Brief Summary

This study is a randomized, open labelled, parallel group, single-centred trail comparing the safety and efficacy of surfactant administration through laryngeal mask airway and endotracheal tube in preterm neonates more than 30 weeks of gestation. This study was designed based on the hypothesis that Surfactant administration through Laryngeal mask airway will decrease the need for intubation in babies with Respiratory distress syndrome , when compared to standard surfactant administration through endotracheal tube in preterm neonates more than 30 weeks of gestation.

    Primary outcomes measured would be the need for mechanical ventilation within 48 hours of intervention. The secondary outcomes measured would be any need for mechanical ventilation, evaluation of pain scores (Neonatal Infant Pain score), duration of oxygen requirement, rate of pneumothorax, compilations related to the interventions, incidence of Sepsis and mortality rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
176
Inclusion Criteria

1.Birth weight of more than 1200 grams 2.Gestational age of more than 30 weeks 3.Chronological age of less than 48 hours 4.Diagnosis of RDS with clinical and radiological criteria 5.Requiring nasal CPAP with Peep of less than 7 and FiO2 between 0.4 to 0.7 6.Hemodynamically stable A written consent will be obtained from the parents / care givers of the infant for willingness for enrolment in the study.

Exclusion Criteria

1.Babies who underwent Endotracheal intubation earlier 2.Analgesia & or sedation during first 6 hours of life 3.APGAR score of less than 3 at 5 minutes of life 4.Babies with Major congenital anomalies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Need for mechanical ventilation within 48 hours of intervention48 hours
Secondary Outcome Measures
NameTimeMethod
1.Any need for mechanical ventilation2.Evaluation of pain (Neonatal Infant Pain score)

Trial Locations

Locations (1)

Number 99, 1ST floor, Department of Neonatology,Institute of child health and hospital for children

🇮🇳

Chennai, TAMIL NADU, India

Number 99, 1ST floor, Department of Neonatology,Institute of child health and hospital for children
🇮🇳Chennai, TAMIL NADU, India
Dr Ramkumaar
Principal investigator
9790971177
rampaediatricsmddm@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.